Ibrance 75 mg/1 (Palbociclib TABLET, FILM COATED) 75 mg/1

Ibrance 75 mg is a prescription medication used in the treatment of certain types of cancer. This film-coated tablet is manufactured by Pfizer Laboratories and is taken orally.

Strength

75 mg/1

Pack Size

3 DOSE PACK in 1 CARTON (0069-0284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (0069-0284-07)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ibrance 75 mg is primarily used in combination with other medications for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic breast cancer. It works by helping to slow down the progression of cancer cells. Patients often wonder, 'What is Ibrance used for?' and the answer is that it is typically prescribed for specific types of breast cancer in postmenopausal women or in combination with other treatments.

Side Effects

Common effects of Ibrance 75 mg may include fatigue, nausea, hair loss, and diarrhea. Some patients may also experience infections, low blood cell counts, and changes in appetite. It is important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

Ibrance 75 mg should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid crushing or breaking the tablets unless instructed to do so. Pregnant women or those planning to become pregnant should consult their doctor before taking this medication.

Avoid Interactions

Ibrance 75 mg may interact with certain medications, including strong CYP3A inhibitors and inducers. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy of Ibrance, so it is advisable to discuss any concerns with a healthcare professional.

Frequently Asked Questions

Ibrance 75 mg is used in combination with other medications for the treatment of certain types of breast cancer.

Ibrance 75 mg is taken orally, typically once daily for a specific number of days in a row, followed by a rest period.

Common side effects may include fatigue, nausea, hair loss, and diarrhea.

Ibrance 75 mg may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Pregnant women or those planning to become pregnant should consult their doctor before taking Ibrance 75 mg.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.